# Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

> **NCT00003653** · PHASE3 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 1386 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** buserelin
- **DRUG:** cyproterone acetate
- **DRUG:** flutamide
- **DRUG:** goserelin
- **DRUG:** leuprolide acetate
- **DRUG:** nilutamide

## Key facts

- **NCT ID:** NCT00003653
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01-05
- **Primary completion:** 2010-10-04
- **Final completion:** 2013-01-10
- **Target enrollment:** 1386 (ACTUAL)
- **Last updated:** 2021-06-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003653, "Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*